<?xml version="1.0" encoding="UTF-8"?>
<mods:mods xmlns="http://www.loc.gov/mods/v3"
           xmlns:flvc="info:flvc/manifest/v1"
           xmlns:dcterms="http://purl.org/dc/terms/"
           xmlns:etd="http://www.ndltd.org/standards/metadata/etdms/1.0/"
           xmlns:mods="http://www.loc.gov/mods/v3"
           xmlns:xlink="http://www.w3.org/1999/xlink"
           xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
           xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-6.xsd"
           version="3.6">
   <titleInfo  lang="eng">
      <title>Towards Optimal Mesenchymal Stem Cell Derived Extracellular Vesicle Therapies</title>
      <subTitle>Impacts of Tissue Source, in Vitro Aging and Adhesive Substrates</subTitle>
   </titleInfo>
   <name  type="personal" authority="local">
      <nameIdentifier type="orcid" typeURI="https://orcid.org/">0009-0007-0579-4056</nameIdentifier>
      <namePart type="family">Liu</namePart>
      <namePart type="given">Yuan</namePart>
      <affiliation>Theses and Dissertations</affiliation>
      <role>
         <roleTerm authority="local" type="text">author</roleTerm>
      </role>
   </name>
   <name 
         type="personal"
         authority="etd-naf"
         authorityURI="https://authorities.lib.fsu.edu/etd-naf/"
         valueURI="https://authorities.lib.fsu.edu/etd-naf/caholmes">
      <namePart type="family">Holmes</namePart>
      <namePart type="given">Christina A. (Christina Andrea)</namePart>
      <affiliation>Theses and Dissertations</affiliation>
      <role>
         <roleTerm authority="local" type="text">professor co-directing dissertation</roleTerm>
      </role>
   </name>
   <name 
         type="personal"
         authority="etd-naf"
         authorityURI="https://authorities.lib.fsu.edu/etd-naf/"
         valueURI="https://authorities.lib.fsu.edu/etd-naf/yli4">
      <namePart type="family">Li</namePart>
      <namePart type="given">Yan</namePart>
      <affiliation>Theses and Dissertations</affiliation>
      <role>
         <roleTerm authority="local" type="text">professor co-directing dissertation</roleTerm>
      </role>
   </name>
   <name 
         type="personal"
         authority="naf"
         authorityURI="http://id.loc.gov/authorities/names/"
         valueURI="http://id.loc.gov/authorities/names/no2018139711">
      <namePart type="family">Suo</namePart>
      <namePart type="given">Zucai</namePart>
      <affiliation>Theses and Dissertations</affiliation>
      <role>
         <roleTerm authority="local" type="text">university representative</roleTerm>
      </role>
   </name>
   <name 
         type="personal"
         authority="etd-naf"
         authorityURI="https://authorities.lib.fsu.edu/etd-naf/"
         valueURI="https://authorities.lib.fsu.edu/etd-naf/scgrant">
      <namePart type="family">Grant</namePart>
      <namePart type="given">Samuel C.</namePart>
      <affiliation>Theses and Dissertations</affiliation>
      <role>
         <roleTerm authority="local" type="text">committee member</roleTerm>
      </role>
   </name>
   <name 
         type="personal"
         authority="etd-naf"
         authorityURI="https://authorities.lib.fsu.edu/etd-naf/"
         valueURI="https://authorities.lib.fsu.edu/etd-naf/tdriscoll2">
      <namePart type="family">Driscoll</namePart>
      <namePart type="given">Tristan</namePart>
      <affiliation>Theses and Dissertations</affiliation>
      <role>
         <roleTerm authority="local" type="text">committee member</roleTerm>
      </role>
   </name>
   <name 
         type="corporate"
         authority="naf"
         authorityURI="http://id.loc.gov/authorities/names/"
         valueURI="http://id.loc.gov/authorities/names/n80126238">
      <namePart>Florida State University</namePart>
      <role>
         <roleTerm authority="rda" type="text">degree granting institution</roleTerm>
      </role>
   </name>
   <name  type="corporate" authority="local">
      <namePart>FAMU-FSU College of Engineering</namePart>
      <role>
         <roleTerm authority="local" type="text">degree granting college</roleTerm>
      </role>
   </name>
   <name  type="corporate" authority="local">
      <namePart>Department of Chemical and Biomedical Engineering</namePart>
      <role>
         <roleTerm authority="local" type="text">degree granting department</roleTerm>
         <roleTerm authority="marcrelator" type="code">dgg</roleTerm>
      </role>
   </name>
   <typeOfResource >text</typeOfResource>
   <genre  authority="rdacontent">text</genre>
   <genre 
          authority="coar"
          authorityURI="http://purl.org/coar/resource_type"
          valueURI="http://purl.org/coar/resource_type/c_db06">doctoral thesis</genre>
   <originInfo >
      <place>
         <placeTerm type="text">Tallahassee, Florida</placeTerm>
      </place>
      <dateIssued encoding="w3cdtf" keyDate="yes">2023</dateIssued>
      <publisher>Florida State University</publisher>
      <issuance>monographic</issuance>
   </originInfo>
   <language >
      <languageTerm type="text">English</languageTerm>
      <languageTerm type="code" authority="iso639-2b">eng</languageTerm>
   </language>
   <physicalDescription >
      <form authority="rdamedia" type="RDA media terms">computer</form>
      <form authority="rdacarrier" type="RDA carrier terms">online resource</form>
      <extent>1 online resource (184 pages)</extent>
      <digitalOrigin>born digital</digitalOrigin>
      <internetMediaType>application/pdf</internetMediaType>
   </physicalDescription>
   <abstract >Recently, therapies utilizing extracellular vesicles (EVs) derived from mesenchymal stromal/stem cells (MSCs) have begun to show promise in clinical trials, such as for the treatment of osteoarthritis, Crohn's disease, graft-vs-host disease, and other conditions. However, EV therapeutic potential varies with MSC tissue source, culture conditions, and in vitro expansion through passaging. To find the optimal MSC source for clinically translatable EV-derived therapies, this study compared the in vitro angiogenic and immunomodulatory potentials and the protein and miRNA cargo compositions of EVs isolated from the two most common clinical sources of adult MSCs, bone marrow and adipose tissue, across different passage numbers. The impact of cell adhesion coatings on EV secretion and therapeutic potential was also analyzed in the two types of primary MSCs and several common cell lines. Primary bone marrow-derived MSCs (BMSCs) and adipose-derived MSCs (ASCs) were isolated from adult female Lewis rats and expanded in vitro to the indicated passage numbers (P2, P4, and P8). MSC surface markers were confirmed by flow cytometry. EV size, number, surface markers, protein content, and morphology were characterized via nanoparticle tracking analysis, western blotting, BCA kit, and transmission electron microscopy, separately. EV immunomodulatory and angiogenic capacity were assessed via qRT-PCR, ELISA, cell proliferation assays, and tube formation assays employing RAW264.7 cells, human umbilical vein endothelial cells (HUVECs), and primary BMSCs. Proteomics and small RNA sequencing were performed for EV cargo profiling. Primary BMSCs, ASCs, NIH3T3 cells and RAW264.7 cells were cultured on type I collagen, poly-l-lysine (PLL), and fibronectin (FN) substrate coatings and compared to uncoated controls. EV production was characterized via nanoparticle tracking analysis, while parental cell viability, cytoskeletal arrangement and expression of adhesion and EV biogenesis genes were assessed on the coatings via live/dead staining, phalloidin staining, and qRT-PCR. EV immunomodulatory capacity was assessed via primary bone marrow- derived macrophage proliferation assay. Our findings suggest that both tissue source and passage number affected EV yield, cargo composition, and therapeutic potentials. For example, ASC-EVs generally showed stronger angiogenic capacity while early passage BMSC-EVs generally displayed stronger immunomodulatory effects in activated macrophages. The effects of cell adhesion coatings on EV production were found to be coating and cell specific, with PLL increasing EV secretion in ASCs while FN increased EV secretion in NIH3T3 cells. Together, our results provide valuable insights towards improved production of clinical MSC-EV therapies.</abstract>
   <note  displayLabel="Submitted Note">A Dissertation submitted to the Department of Chemical and Biomedical Engineering in partial fulfillment of the requirements for the degree of Doctor of Philosophy.</note>
   <note  displayLabel="Date of Defense">November 6, 2023.</note>
   <note  displayLabel="Bibliography Note">Includes bibliographical references.</note>
   <note  displayLabel="Advisory Committee">Christina Andrea Holmes, Professor Co-Directing Dissertation; Yan Li, Professor Co-Directing Dissertation; Zucai Suo, University Representative; Samuel C. Grant, Committee Member; Tristan Patrick Driscoll, Committee Member.</note>
   <subject 
            authority="lcsh"
            authorityURI="http://id.loc.gov/authorities/subjects/"
            valueURI="http://id.loc.gov/authorities/subjects/sh85014237">
      <topic>Biomedical engineering</topic>
   </subject>
   <identifier  type="IID">Liu_fsu_0071E_18405</identifier>
   <extension >
      <etd:degree>
         <etd:name>Doctor of Philosophy</etd:name>
         <etd:level>Doctoral</etd:level>
         <etd:discipline>Chemical and Biomedical Engineering</etd:discipline>
      </etd:degree>
      <flvc:flvc>
         <flvc:owningInstitution>FSU</flvc:owningInstitution>
         <flvc:submittingInstitution>FSU</flvc:submittingInstitution>
      </flvc:flvc>
   </extension>
   <recordInfo >
      <recordCreationDate encoding="w3cdtf">2024-10-30T13:17:45.832113-04:00</recordCreationDate>
      <descriptionStandard>rda</descriptionStandard>
   </recordInfo>
</mods:mods>
